REVELATION BIOSCIENCES, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-8.9M | $-15.0M | $-120.3K | $-10.8M | $-12.0M | $-1.6M | $-3.6K |
| Depreciation & Amortization | — | — | — | — | — | — | — |
| Depreciation | $27.1K | $27.9K | $25.0K | $25.0K | $16.8K | — | — |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | $595.4K | $168.9K | $155.7K | $301.1K | $470.9K | — | — |
| Net Cash from Operating Activities | $-8.3M | $-18.3M | $-7.3M | $-11.2M | $-11.1M | $-216.7K | — |
| Investing Activities | |||||||
| Capital Expenditures | — | $19.2K | — | — | $132.0K | — | — |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-19.2K | — | — | $-132.0K | $-74.0M | — |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | $35.5M | — | — |
| Net Cash from Financing Activities | $12.5M | $12.8M | $14.0M | $15.2M | $8.0M | $74.3M | — |
| Net Change in Cash | — | — | — | — | — | $11.7K | — |
| Free Cash Flow | — | $-18.3M | — | — | $-11.2M | — | — |